Back
Allegion PLC 10K Form
Sell
41
ALLE
Allegion PLC
Last Price:
141.29
Seasonality Move:
2.22%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-25 | 10Q | ALLE/Allegion PLC Quarterly |
| 2023-10-31 | 10Q | ALLE/Allegion PLC Quarterly |
| 2023-07-26 | 10Q | ALLE/Allegion PLC Quarterly |
| 2023-04-26 | 10Q | ALLE/Allegion PLC Quarterly |
| 2022-10-27 | 10Q | ALLE/Allegion PLC Quarterly |
| 2022-07-28 | 10Q | ALLE/Allegion PLC Quarterly |
Receive ALLE News And Ratings
See the #1 stock for the next 7 days that we like better than ALLE
ALLE Financial Statistics
Sales & Book Value
| Annual Sales: | $3.65B |
|---|---|
| Cash Flow: | $212M |
| Price / Cash Flow: | 21.29 |
| Annual Sales: | $18.07 |
| Price / Book: | 7.82 |
Profitability
| EPS (TTM): | 6.51000 |
|---|---|
| Net Income (TTM): | $572M |
| Gross Margin: | $1.58B |
| Return on Equity: | 41.47% |
| Return on Assets: | 12.69% |
Allegion PLC Earnings Forecast
Key Allegion PLC Financial Ratios
- The Gross Profit Margin over the past 13 years for ALLE is 43.32%.
- The Selling, General & Administrative Expenses for ALLE have been equal to 23.71% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 17.23% of Operating Income.
- The Net Earning history of ALLE is 14.80% of Total Revenues.
- Per Share Earnings over the last 13 years have been positive in 7 years.
Allegion PLC Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Building Products |
| Sector: | Industrials |
| Current Symbol: | ALLE |
| CUSIP: | G0176J |
| Website: | allegion.com |
Debt
| Debt-to-Equity Ratio: | 1.53 |
|---|---|
| Current Ratio: | 1.71 |
| Quick Ratio: | 1.23 |
Price-to-Earnings
| Trailing P/E Ratio: | 23.1 |
|---|---|
| Forward P/E Ratio: | 18.14 |
ALLE Technical Analysis vs Fundamental Analysis
Sell
41
Allegion PLC (ALLE)
is a Sell
Is Allegion PLC a Buy or a Sell?
-
Allegion PLC stock is rated a Sell
The current Allegion PLC [ALLE] share price is $141.38. The Score for ALLE is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.